この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2018/4/21 分で読めます
Prescription Polyethylene Glycol 3350; Denial of a Hearing and Order Withdrawing Approval of Abbreviated New Drug Applications
ローカル自動翻訳 · 情報源の原言語
概要
The Commissioner of Food and Drugs (the Commissioner) is denying requests for a hearing and issuing an order withdrawing approval of abbreviated new drug applications (ANDAs) for certain prescription laxatives with the active ingredient polyethylene glycol 3350 (PEG 3350), listed in this document, because the drug products are misbranded under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →